(Q36511692)

14 August 2017

1 reference

title

Meta-analysis in the assessment of treatment outcome (English)

1 reference

14 August 2017

1 reference

John Geddes

1

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

Journal of Psychopharmacology

14 August 2017

published in

1 reference

14 August 2017

volume

20

1 reference

14 August 2017

issue

4 Suppl

1 reference

14 August 2017

page(s)

67-71

1 reference

A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

The 2000 EBCTCG overview: a widening gap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Meta-analysis and its problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Meta-analysis of brain weight in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Meta-analysis of continuous outcome data from individual patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

The medical review article: state of the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Why sources of heterogeneity in meta-analysis should be investigated

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Content and quality of 2000 controlled trials in schizophrenia over 50 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

Meta-analysis of ordinal outcomes using individual patient data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066056

21 January 2018

Identifiers

DOI

10.1177/1359786806066056

1 reference

14 August 2017

1 reference